Lifestyle intervention up-regulates gene and protein levels of molecules involved in insulin signaling in the endometrium of overweight/obese women with polycystic ovary syndrome

Human Reproduction

Volumn 29, Issue 7, 2014, Pages 1526-1535

  Ujvari, D ^a   Hulchiy, M ^a   Calaby, A ^a   Nybacka, A ^a   Bystrom B ^a   Hirschberg, A L ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

endometrium; glucose transporter 1; glucose transporter 4; insulin receptor substrate 1; PCOS

Indexed keywords

GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 4; INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; MESSENGER RNA; HORMONE; INSULIN RECEPTOR SUBSTRATE; SLC2A1 PROTEIN, HUMAN; SLC2A4 PROTEIN, HUMAN;

ADULT; ANOVULATION; ARTICLE; BODY MASS; DIET; ENDOMETRIUM; EXERCISE; FEMALE; GENE CONTROL; HUMAN; HYPERANDROGENISM; LIFESTYLE; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; OBESITY; OVARY POLYCYSTIC DISEASE; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; WEIGHT REDUCTION; BLOOD; CASE CONTROL STUDY; GENE EXPRESSION REGULATION; HOMEOSTASIS; METABOLISM; UPREGULATION; YOUNG ADULT;

ADULT; BODY MASS INDEX; CASE-CONTROL STUDIES; DIET; ENDOMETRIUM; FEMALE; GENE EXPRESSION REGULATION; GLUCOSE TRANSPORTER TYPE 1; GLUCOSE TRANSPORTER TYPE 4; HOMEOSTASIS; HORMONES; HUMANS; INSULIN; INSULIN RECEPTOR SUBSTRATE PROTEINS; LIFE STYLE; OBESITY; OVERWEIGHT; POLYCYSTIC OVARY SYNDROME; RNA, MESSENGER; UP-REGULATION; YOUNG ADULT;

EID: 84902654682     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/deu114     Document Type: Article

References (35)

1. Bellver J, Martinez-Conejero JA, Labarta E, Alama P, Melo MAB, Remohi J, Pellicer A, Horcajadas JA. Endometrial gene expression in the window of implantation is altered in obese women especially in association with polycystic ovary syndrome. Fertil Steril 2011;95:2335-U2254.
2. Boomsma CM, Eijkemans MJC, Hughes EG, Visser GHA, Fauser BCJM, Macklon NS. A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome. Hum Reprod Update 2006;12:673-683.
3. Carvajal R, Rosas C, Kohan K, Gabler F, Vantman D, Romero C, Vega M. Metformin augments the levels of molecules that regulate the expression of the insulin-dependent glucose transporter GLUT4 in the endometria of hyperinsulinemic PCOS patients. Hum Reprod 2013;28:2235-2244.
4. Chang W, Goodarzi MO, Williams H, Magoffin DA, Pall M, Azziz R. Adipocytes from women with polycystic ovary syndrome demonstrate altered phosphorylation and activity of glycogen synthase kinase 3.Fertil Steril 2008;90:2291-2297.
5. Chittenden BG, Fullerton G, Maheshwari A, Bhattacharya S. Polycystic ovary syndrome and the risk of gynaecological cancer: a systematic review. Reprod Biomed Online 2009;19:398-405.
6. Corbould A, Kim YB, Youngren JF, Pender C, Kahn BB, Lee A, Dunaif A. Insulin resistance in the skeletal muscle of women with PCOS involves intrinsic and acquired defects in insulin signaling. Am J Physiol Endocrinol Metab 2005;288:E1047-E1054.
7. Corbould A, Zhao HY, Mirzoeva S, Aird F, Dunaif A. Enhanced mitogenic signaling in skeletal muscle of women with polycystic ovary syndrome. Diabetes 2006;55:751-759.
8. Diamanti-Kandarakis E, Dunaif A. Insulin resistance and the polycystic ovary syndromerevisited: an update on mechanisms and implications. Endocr Rev 2012;33:981-1030.
9. Dubicke A, Fransson E, Centini G, Andersson E, Bystrom B, Malmstrom A, Petraglia F, Sverremark-Ekstrom E, Ekman-Ordeberg G. Pro-inflammatory and anti-inflammatory cytokines in human preterm and term cervical ripening. J Reprod Immunol 2010;84:176-185.
10. Dunaif A, Graf M, Mandeli J, Laumas V, Dobrjansky A. Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia. J Clin Endocrinol Metab 1987;65:499-507.
11. Dunaif A,WuXQ, Lee A, Diamanti-Kandarakis E. Defects in insulin receptor signaling in vivo in the polycystic ovary syndrome (PCOS). Am J Physiol Endocrinol Metab 2001;281:E392-E399.
12. Fornes R, Ormazabal P, Rosas C, Gabler F, Vantman D, Romero C, Vega M. Changes in the expression of insulin signaling pathway molecules in endometria from polycystic ovary syndrome women with or without hyperinsulinemia. Mol Med 2010;16:129-136.
13. Frolova AI, Moley KH. Quantitative analysis of glucose transportermRNAsin endometrial stromal cells reveals critical role of GLUT1 in uterine receptivity. Endocrinology 2011;152:2123-2128.
14. Giudice LC. Endometrium in PCOS: implantation and predisposition to endocrine CA. Best Pract Res Clin Endocrinol Metab 2006;20:235-244.
15. Goodarzi MO, Dumesic DA, Chazenbalk G, Azziz R. Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat Rev Endocrinol 2011;7:219-231.
16. Gual P, Le Marchand-Brustel Y, Tanti JF. Positive and negative regulation of insulin signaling through IRS-1 phosphorylation. Biochimie 2005;87:99-109.
17. Isaksson E, Wang H, Sahlin L, von Schoultz B, Masironi B, von Schoultz E, Cline JM. Expression of estrogen receptors (alpha, beta) and insulin-like growth factor-I in breast tissue from surgically postmenopausal cynomolgus macaques after long-term treatment with HRT and tamoxifen. Breast 2002; 11:295-300.
18. Kohan K, Carvajal R, Gabler F, Vantman D, Romero C, Vega M. Role of the transcriptional factors FOXO1and PPARGon gene expression ofSLC2A4 in endometrial tissue from women with polycystic ovary syndrome. Reproduction 2010;140:123-131.
19. Larsen TM, Dalskov SM, van Baak M, Jebb SA, Papadaki A, Pfeiffer AFH, Martinez J, Handjieva-Darlenska T, Kunesova M, Pihlsgard M et al. Diets with high or low protein content and glycemic index for weight-loss maintenance. N Engl J Med 2010;363:2102-2113.
20. Legro RS, Kunselman AR, DodsonWC,Dunaif A. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab 1999;84:165-169.
21. Li M, Youngren JF, Dunaif A, Goldfine ID, Maddux BA, Zhang BB, Evans JL. Decreased insulin receptor (IR) autophosphorylation in fibroblasts from patients with PCOS: effects of serine kinase inhibitors and IR activators. J Clin Endocrinol Metab 2002;87:4088-4093.
22. Mioni R, Chiarelli S, Xamin N, Zuliani L, Granzotto M, Mozzanega B, Maffei P, Martini C, Blandamura S, Sicolo N et al. Evidence for the presence of glucose transporter 4 in the endometrium and its regulation in polycystic ovary syndrome patients. J Clin Endocrinol Metab 2004;89:4089-4096.
23. Moran LJ, Noakes M, Clifton PM, Tomlinson L, Norman RJ. Dietary composition in restoring reproductive and metabolic physiology in overweight women with polycystic ovary syndrome. J Clin Endocrinol Metab 2003;88:812-819.
24. Moran LJ,MissoML,Wild RA,Norman RJ. Impaired glucose tolerance, type 2 diabetes andmetabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update 2010;16:347-363.
25. Moran LJ, Hutchison SK, Norman RJ, Teede HJ. Lifestyle changes in women with polycystic ovary syndrome. Cochrane Database Syst Rev 2011; 7:CD007506.
26. Mozzanega B, Mioni R, Granzotto M, Chiarelli S, Xamin N, Zuliani L, Sicolo N, Marchesoni D, Vettor R. Obesity reduces the expression of GLUT4 in the endometrium of normoinsulinemic women affected by the polycystic ovary syndrome. Ann N Y Acad Sci 2004;1034:364-374.
27. Mueckler M. Family of glucose-transporter genes-implications for glucose-homeostasis and diabetes. Diabetes 1990;39:6-11.
28. NybackaA , Carlströ K, Stahle A, Nyren S, Hellströ PM, Hirschberg AL. Randomized comparison of the influence of dietary management and/or physical exercise on ovarian function and metabolic parameters in overweight women with polycystic ovary syndrome. Fertil Steril 2011; 96:1508-1513.
29. Nybacka A , Carlströ K, Fabri F, Hellströ PM, Hirschberg AL. Serum antimullerian hormone in response to dietary management and/or physical exercise in overweight/obese women with polycystic ovary syndrome: secondary analysis of a randomized controlled trial. Fertil Steril 2013;100:1096-1102.
30. Rosas C, Gabler F,Vantman D,Romero C, Vega M. Levels of Rabs andWAVE family proteins associated with translocation of GLUT4 to the cell surface in endometria from hyperinsulinemic PCOS women. Hum Reprod 2010; 25:2870-2877.
31. Shang KW, Jia X, Qiao J, Kang JH, Guan YF. Endometrial abnormality in women with polycystic ovary syndrome. Reprod Sci 2012;19:674-683.
32. Sodergard R, Backstrom T, Shanbhag V, Carstensen H. Calculation of free and bound fractions of testosterone and estradiol-17 beta to human plasma proteins at body temperature. J Steroid Biochem 1982;16:801-810.
33. Tonblom SA, Klimaviciute A, Byströ B, Chromek M, Brauner A, Ekman-Ordeberg G. Non-infected preterm parturition is related to increased concentrations of IL-6, IL-8 and MCP-1 in human cervix. Reprod Biol Endocrinol 2005;3:39.
34. Zhai J, Liu CX, Tian ZR, Jiang QH, Sun YP. Effects of metformin on the expression of GLUT4 in endometrium of obese women with polycystic ovary syndrome. Biol Reprod 2012;87:29.
35. Zhang L, Liao QP. Effects of testosterone and metformin on glucose metabolism in endometrium. Fertil Steril 2010;93:2295-2298.